刺络放血联合异维A酸红霉素凝胶治疗寻常痤疮疗效观察

摘要

目的：观察刺络放血联合异维A酸红霉素凝胶治疗寻常痤疮的临床疗效。方法将93例寻常痤疮患者随机分为治疗组47例和对照组46例。治疗组采用刺络放血联合异维A酸红霉素凝胶治疗，对照组采用单纯外涂异维A酸红霉素凝胶治疗。治疗2个疗程后比较两组皮损数目，并评定疗效。结果两组治疗后皮损(丘疹、脓疱、结节)数目与同组治疗前比较，差异均具有统计学意义(P＜0.01)。治疗组治疗后皮损数目与对照组比较，差异均具有统计学意义(P＜0.05)。治疗组总有效率为93.6%，对照组为78.3%，两组比较差异具有统计学意义(P＜0.05)。结论刺络放血联合异维A酸红霉素凝胶是一种治疗寻常痤疮的有效方法。%Objective To observe the clinical efficacy of collateral bloodletting plus Isotretinoin Erythromycin gel in treating acne vulgaris.Method Ninety-three patients with acne vulgaris were randomized into a treatment group of 47 cases and a control group of 46 cases. The treatment group was intervened by collateral bloodletting plus Isotretinoin Erythromycin gel, while the control group was by using the gel alone. Two treatment courses later, the skin lesions count was compared and the therapeutic efficacy was evaluated.Result After treatment, the skin lesions count (including papules, pustules, and nodules) was significantly different from that before treatment in both groups (P<0.01). There was a significant difference in comparing the skin lesions count between the two groups after intervention (P<0.05). The total effective rate was 93.6% in the treatment group versus 78.3% in the control group, and the difference was statistically significant (P<0.05).Conclusion Collateral bloodletting plus Isotretinoin Erythromycin gel is an effective approach in treating acne vulgaris.